DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Lip GY, Rasmussen LH, Olsson SB. , et al; Steering Committee.
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.

Thromb Res 2011;
127 (02) 91-99

Download Bibliographical Data

Access:
Access:
Access: